Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis

Randomised trials have established the importance of oxaliplatin (O) and irinotecan (I) in advanced colorectal cancer (CRC). However, patients enrolled in clinical studies represent a restricted population and little is known about the use of O and I in the general population and the subsequent outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Damianovich, D, Adena, M, Tebbutt, N C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360040/
https://www.ncbi.nlm.nih.gov/pubmed/17285136
http://dx.doi.org/10.1038/sj.bjc.6603590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360040/
https://www.ncbi.nlm.nih.gov/pubmed/17285136
http://dx.doi.org/10.1038/sj.bjc.6603590

Ejemplares similares